Evidence map›Paper›PMID 40100109›Full record

ArticleSarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG2025

Cranial MRI in neurosarcoidosis: Imaging patterns and nationwide clinical correlations.

Elif Uzun Ata, Serdar Can Guven, Orhan Kucuksahin, Mustafa Mahir Ulgu, Suayip Birinci

Abstract read
In one paragraph

Article in Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Elif Uzun AtaAnkara Bilkent City Hospital, Clinic of Radiology, Ankara, Turkey.
Serdar Can GuvenAnkara Bilkent City Hospital, Clinic of Rheumatology, Ankara, Turkey.ORCID 0000-0003-1965-9756
Orhan KucuksahinAnkara Yıldırım Beyazıt University Medical School, Department of Internal Medicine, Division of Rheumatology, Ankara, Turkey.
Mustafa Mahir UlguMinistry of Health, General Directorate of Health Information Systems, Ankara, Turkey.
Suayip BirinciMinistry of Health, Deputy Minister, Ankara, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectTo investigate cranial MRIs of sarcoidosis pateints by defining typical and atypical findings and their relations with patient characteristics and other disease manifestations. MATERIALS AND

methodsA nationwide cohort was formed from patients with an entering ICD-10 code for sarcoidosis twice at least 1 month apart and any tissue biopsy result with the word "granuloma" defined in the biopsy report were considered to have sarcoidosis. Data regarding patients were obtained by using Turkish Ministry of Health National Electronic Data base. Patients of the formed cohort were investigated for the presence of a cranial imaging at any time.

results4367 patients were defined as sarcoidosis and enrolled in the study. 1659 cranial imagings in 689 patients were investigated. 1175 imagings were deemed suitable and evaluated. 3.4% of the patients had findings suggestive of sarcoidosis. Most common lesions were leptomeningeal or dural thickening with/without contrast material enhancement and midbrain/brainstem lesions. Presence of pulmonary sarcoidosis was the only significant factor with a negative predictive effect for patients to have typical findings. DISCUSSION: Among sarcoidosis patients with MRI we detected 3.4% of them had findings suggestive of CNS sarcoidosis. Absence of pulmonary involvement was observed to be predictor for occurrence of typical manifestations.

Identifiers

PMID40100109
PMCPMC12013691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.